MRNA is expected to report earnings to fall 8,833.33% to -261 cents per share on February 20
Q4'24
Est.
$-2.62
Q3'24
Beat
by $1.95
Q2'24
Beat
by $0.02
Q1'24
Beat
by $0.48
Q4'23
Beat
by $1.54
The last earnings report on November 07 showed earnings per share of 2 cents, beating the estimate of -191 cents. With 7.34M shares outstanding, the current market capitalization sits at 14.22B.